Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Leo B Snel"'
Publikováno v:
Journal of Tissue Engineering, Vol 3 (2012)
This article discusses nonclinical and clinical data regarding the safety of recombinant human platelet-derived growth factor-BB as a component of the Augment ® Bone Graft ( Augment ). Augment is a bone graft substitute intended to be used as an alt
Externí odkaz:
https://doaj.org/article/315185d48cc7450ea345226f434ac9e1
Autor:
Christopher K. Hee, Luis A. Solchaga, Joshua S. Dines, Alison Bendele, Vivek Shah, Leo B. Snel, Hans K. Kestler
Publikováno v:
Journal of Orthopaedic Research. 32:145-150
This study compared the effect of intra-tendon (IT) delivery of recombinant human platelet-derived growth factor-BB (rhPDGF-BB), platelet-rich plasma (PRP) and corticosteroids in a rat tendinopathy model. Seven days after collagenase induction of ten
Autor:
Gary E. Friedlaender, Leo B. Snel, Samuel E. Lynch, Bill Beasley, Mark Glazebrook, Christopher W. DiGiovanni
Publikováno v:
Current Orthopaedic Practice. 24:476-481
Publikováno v:
Current Pharmaceutical Design. 19:3384-3390
Recombinant human PDGF BB homodimer (rhPDGF-BB) is a potent recruiter of, and strong mitogenic factor for, cells crucial to musculoskeletal tissue repair, including mesenchymal stem cells (MSCs), osteogenic cells and tenocytes. rhPDGF-BB also upregul
Autor:
Jack Ratliff, Christopher K. Hee, A. Simon Turner, Luis A. Solchaga, Howard B. Seim, Samuel E. Lynch, Jeffrey O. Hollinger, Leo B. Snel, Dean J. Aguiar
Publikováno v:
Spine. 37:E461-E467
Study design This study was designed to determine whether Augment Bone Graft (Augment, Biomimetic Therapeutics, Inc., Franklin, TN) and Augment Injectable Bone Graft (Augment Injectable, Biomimetic Therapeutics, Inc., Franklin, TN), 2 combination dev
Autor:
Luis A, Solchaga, Alison, Bendele, Vivek, Shah, Leo B, Snel, Hans K, Kestler, Joshua S, Dines, Christopher K, Hee
Publikováno v:
Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 32(1)
This study compared the effect of intra-tendon (IT) delivery of recombinant human platelet-derived growth factor-BB (rhPDGF-BB), platelet-rich plasma (PRP) and corticosteroids in a rat tendinopathy model. Seven days after collagenase induction of ten
Publikováno v:
Clinical drug investigation. 33(2)
Augment(®) Bone Graft is a bone graft substitute intended to be used as an alternative to autologous bone graft in the fusion of hindfoot and ankle joints. Augment(®) Bone Graft is a combination device comprised of beta-tricalcium phosphate (β-TCP
Autor:
Jeffrey O. Hollinger, Leo B. Snel, Christopher K. Hee, Hans K. Kestler, Samuel E. Lynch, Pedro Alvarez, Luis A. Solchaga
Publikováno v:
The Journal of craniofacial surgery. 23(1)
The specialty of craniofacial surgery is broad and includes trauma, aesthetics, reconstruction of congenital deformities, and regeneration of tissues. Moreover, craniofacial surgery deals with a diverse range of tissues including both "soft" and "har